and tell him to buy AVRO with a 1 for 1 stock deal

AVRO has a singular focus in LSDs... and a close connection to the LSD community and market, in which Fabry is the largest indication

and AVRO now has $160M in cash (82M as of 3/31 plus 88M from their recent deal) with only a $50M mkt cap... that would give SM a much needed extension to his liquidity problem... and as an added bonus, it would then make sense for SGMO to go-it-alone in Fabry... AVRO's 4-5 other indications in LSDs would be right behind Fabry and the market would love that totally synergistic acquisition... i.e. a commercial organization that is focused on the entire LSD market, not just a sub-critical Fabry market which is not viable for a go-it-alone SGMO